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OBJECTIVE—Increase in adipose cAMP-responsive element–
binding protein (CREB) activity promotes adipocyte dysfunction
and systemic insulin resistance in obese mice. This is achieved
by increasing the expression of activating transcription factor 3
(ATF3). In this study, we investigated whether impaired expres-
sion of the inducible cAMP early repressor (ICER), a transcrip-
tional antagonist of CREB, is responsible for the increased CREB
activity in adipocytes of obese mice and humans.
RESEARCH DESIGN AND METHODS—Total RNA and nu-
clear proteins were prepared from visceral adipose tissue (VAT)
of human nonobese or obese subjects and white adipose tissue
(WAT) of C57Bl6-Rj mice that were fed with normal or high-fat
diet for 16 weeks. The expression of genes was monitored by
real-time PCR, Western blotting, and electromobility shift assays.
RNA interference was used to silence the expression of Icer.
RESULTS—The expression of Icer/ICER was reduced in VAT
and WAT of obese humans and mice, respectively. Diminution
of Icer/ICER was restricted to adipocytes and was accompanied
by a rise of Atf3/ATF3 and diminution of Adipoq/ADIPOQ and
Glut4/GLUT4. Silencing the expression of Icer in 3T3-L1 adipo-
cytes mimicked the results observed in human and mice cells and
hampered glucose uptake, thus conﬁrming the requirement of
Icer for appropriate adipocyte function.
CONCLUSIONS—Impaired expression of ICER contributes to
elevation in CREB target genes and, therefore, to the development
of insulin resistance in obesity. Diabetes 60:3169–3174, 2011
A ccumulation of visceral fat in obesity is a strongrisk factor for life-threatening diseases, such astype 2 diabetes, atherosclerosis, polycystic ovarysyndrome, nonalcoholic fatty liver disease, and
certain types of cancer (1–4). Increased adiposity is asso-
ciated with impairment in glucose uptake in adipocytes,
which in part result from the diminished expression of
GLUT4 (5). Parallel to defective glucose metabolism, adi-
pocytes display reduced production of the insulin-sensitizer
adiponectin (Adipoq) (6,7). This dysregulation is considered
as part of a cross-talk linking adiposity to overall insulin
resistance in obesity (8). An important mechanism respon-
sible for decreased level of Glut4 and Adipoq in obesity
is now advanced (9). This involves the cAMP-responsive
element–binding protein (CREB) transcriptional factors (9).
Transcriptional activity of Creb is abnormally elevated in
adipocytes of obese mice fed with a high-fat diet (HFD),
resulting in elevation of the expression of its target gene,
Atf3 (9). In turn, Atf3 suppresses the expression of Glut4
and Adipoq and, thereby, disrupts insulin action in adipo-
cytes and causes systemic insulin resistance (9). The im-
pact of increased Creb activity has been further validated
by overexpressing a dominant-negative form of Creb in
adipocytes (9). Mice with Creb inactivation in adipocytes
have improved whole-body insulin sensitivity and glucose
homeostasis but similar fat mass and body weight to con-
trol animals (9). The activity of the CREB factors is ﬁnely
tuned by the level of the inducible cAMP early repressor
(ICER). ICER represses gene transcription by binding to
the CRE sequence within the promoters (10). Typically,
ICER plays a dominant-negative role by competing with
all cAMP-responsive transcriptional activators of the CREB,
CRE modulator (CREM), and activating transcription factor
families for binding to CRE (11). Elevation of ICER levels is
normally transient, and dysregulation in the expression of this
repressor leads to diverse pathologies (11–14). In this article,
we tested the hypothesis that the activating transcription
factor 3 (ATF3)–mediated reduction of GLUT4 and ADIPOQ
in adipocytes is the consequence of diminished ICER.
RESEARCH DESIGN AND METHODS
Animal experimentation. All procedures on mice were performed according
to the Swiss legislation for animal experimentation. Six-week-old C57Bl6-Rj male
mice were obtained from the Janvier Breeding Centre (Le Genest-Saint-Isle,
France). Diets and hyperinsulemic-euglycemic clamps were realized as pre-
viously described (15). Epididymal visceral adipose tissue (VAT) was extracted
for total RNA and protein preparation in killed animals.
Biopsies and RNA preparation. Approximately 5 cm3 of VAT was obtained
at the level of the omentum from ﬁve obese white women (BMI .35 kg/m2)
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who were referred for weight reduction surgery and ﬁve nonobese white
women (24, BMI ,28 kg/m2) (16). All patients provided informed consent,
and the study was approved by the institutional review board (16). The criteria
for exclusion and phenotyping are those previously described (16). Total RNA
was isolated from adipose tissues and different cell fractions with the TriPure
isolation reagent (Roche) as previously described (17). The procedure for
preparation of adipocytes and stroma vascular fraction (SVF) was performed
as previously described (18).
Materials. The antibodies against CREM that recognize ICER were provided
by E. Lalli (Institut de Pharmacologie Moléculaire et Cellulaire, Nice Univer-
sity, Valbonne, France). The antibodies against hairy and enhancer of Split-1
(HES-1), CREB1, ATF3, and histone deacetylase 1 (HDAC1) were obtained
from Santa Cruz Biotechnology (Santa Cruz, CA).
Cell culture and transfection. Culture and differentiation of 3T3-L1 cells
were conducted as previously described (19). The 19-nucleotide small inter-
fering RNA (siRNA) duplex (siICER) was synthesized by Mycrosynth AG
(Balgach, Switzerland). For overexpression and silencing of Icer, 3T3-L1 adi-
pocytes on day 7 postdifferentiation were electroporated with either the
plasmid coding for Icer Ig (ICER) or siRNAs (12) using the GenePulser XCell
(Bio-Rad).
Western blotting, quantitative PCR, nuclear extract preparation, and
electromobility shift assay (EMSA). Nuclear protein extracts, Western
blotting, EMSA, and real-time PCR were conducted as previously described (12).
PCR assays were carried out on a Bio-Rad MyiQ single-color, real-time PCR
detection system using the Bio-Rad iQ SYBR Green Supermix, with 100 nmol/L
primers and 1 ml of template per 20 ml of PCR and an annealing temperature
of 60°C. The primer sequences are available in the Supplementary Data.
2-Deoxyglucose uptake assay. 2-Deoxyglucose (2-DOG) uptake assays was
conducted on fully differentiated 3T3-L1 adipocytes (days 7 and 8) as previously
described (20). Adipocytes were treated without (basal) or with insulin (100
pmol/L) for 10 min. 2-[3H]DOG (0.1 mCi; ﬁnal concentration, 0.01 mmol/L) and
5 mmol/L cold 2-DOG were then added for an additional 10 min at 37°C.
Statistical analysis. The experiments including two groups were analyzed by
Student t test or with the nonparametric equivalent Wilcoxon.
RESULTS
Obese mice fed with an HFD display similar metabolic dis-
orders to those observed in humans (21,22). The diet indeed
led to increased mouse body weight, hyper-insulinemia,
hyperglycemia, and insulin resistance, as indicated by a
marked decrease in glucose infusion rate compared with
littermates fed with chow diet (Supplementary Table 1). In
this model, elevation in the transcriptional activity of Atf3
downregulates the expression of Glut4 and Adipoq in
white adipose tissue (WAT), thereby contributing to sys-
temic insulin resistance (9). In agreement with these data,
we found an increase in the abundance of Atf3 and de-
creased expression of Glut4 and Adipoq in WAT of obese
mice when compared with control animals (Fig. 1A and C).
The rise of Atf3 was associated with a striking drop in Icer
content in WAT of obese mice when compared with con-
trol animals both after fasting (Fig. 1A and C) or fed con-
ditions (data not shown), indicating that the reduction in
Icer in HFD-induced obese mice is independent from the
nutritional status. To conﬁrm the data obtained in mice,
we analyzed adipose tissues from human nonobese and
obese subjects. In agreement with the data found in ani-
mals, we detected a smaller amount of ICER mRNA in the
VAT of obese subjects (Fig. 1B). In contrast, the expres-
sion of ICER was signiﬁcantly increased in subcutaneous
adipose tissue of obese individuals (Supplementary Fig. 1).
These results indicate that VAT and subcutaneous adipose
tissue dysfunctions are likely to rely on distinct mechanisms.
As it is the excess of visceral rather than subcutaneous fat
that is more associated with an increased risk of devel-
oping cardiovascular disease and metabolic syndrome (23),
we chose to concentrate our study on VAT. Reduction of
ICER mRNA in VAT of obese individuals was associated
with an increase in the expression of the CREB target
gene ATF3 and decreased levels of ADIPOQ and GLUT4
(Fig. 1B). EMSAs were next done to conﬁrm changes in
binding activities of Icer and Creb. Nuclear proteins from
WAT of obese mice were incubated with a labeled oligo-
nucleotide corresponding to the cAMP response element
(CRE) (12). A fast migrating band was observed in WAT of
control mice, which was markedly reduced in obese mice
(Fig. 1D). On the other hand, a slower migrating pattern
appeared in WAT of obese mice that is almost undetectable
in control animals (Fig. 1D). The lower band was identiﬁed
as Icer because it comigrates with exogenously expressed
ICER-Ig, and the formation of this complex was selectively
abrogated by the addition of an anti-CREM antibody (Fig. 1E).
In the presence of an anti-Creb1 antibody, the migration of
the upper band observed in WAT of obese mice was slower
(Fig. 1F). This result indicates that nuclear extracts of WAT
from obese mice display an increase in Creb binding activity
that coincides with a reduction in Icer expression. In support
of this result, although the binding pattern corresponding to
ICER in VAT was different from WAT, the activity of this
factor was reduced in obese individuals (Fig. 1G and H). The
diminution in ICER activity was associated with a slower mi-
grating complex in VAT from obese individuals, which was
identiﬁed as the CREB factor (Fig. 1I and J). Various stimuli,
including insulin, can elicit Creb activity (24,25). In line with
this, we found that insulin infusion elicited a 16-fold increase
in the expression of Icer in control mice (Supplementary
Fig. 2). As anticipated, insulin-induced Icer expression
was abolished in insulin-resistant WAT of obese mice,
indicating that induction of Icer is also defective in obese
animals.
The drop of Icer in VAT and WAT of obese human and
mice, respectively, was restricted to the adipocyte fraction
(Fig. 2A and B). Indeed, ICER expression was higher in
SVF of obese subjects (Fig. 2B) whereas it was unchanged
in SVF of obese mice (Fig. 2A). The differences in SVF Icer
levels in humans and mice may possibly indicate a differ-
ential regulation between species associated with obesity.
As anticipated, the decrease in Icer/ICER level in adipo-
cytes paralleled the rise in the mRNA level of Atf3/ATF3
(Fig. 2C and D) and the diminution in Adipoq/ADIPOQ and
Glut4/GLUT4 levels (Fig. 2C and D).
To conﬁrm the regulation of Atf3 by Icer, a plasmid
encoding for Icer-Ig was introduced by electroporation
into 3T3-L1 adipocytes. Western blotting and EMSA experi-
ments revealed a high expression of Icer (Supplementary
Fig. 3). Overexpression of Icer-Ig led to reduction in Atf3
mRNA (Fig. 3A) and, consequently, an increase of Glut4
and Adipoq levels (Fig. 3A). On the other hand, silencing
of Icer by RNA interference elevated the contents of Atf3
and diminished the abundance of Glut4 and Adipoq both
in 3T3-L1 adipocytes (Fig. 3B and C) and ﬁbroblasts (Sup-
plementary Fig. 4). As expected, gene dysregulation evoked
by Icer silencing resulted in impairment of insulin-induced
2-DOG uptake in 3T3-L1 adipocytes (Fig. 3D).
DISCUSSION
Augmentation of Creb activity in adipocytes is responsible
for the elevation in Atf3 expression in HFD-induced obese
mice (9). In turn, the rise of Atf3 reduces Adipoq and Glut4
contents, thus promoting systemic insulin resistance (9).
In this report, we provide evidence that defective expres-
sion of ICER, a natural antagonist of the CREB transcrip-
tional activity (10) is responsible for increased expression
of ATF3 and adipocyte dysfunction caused by CREB in
obesity (Fig. 4). We found that diminution of ICER/Icer
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FIG. 1. Examination of Icer/ICER level in adipose tissues of obese mice and human subjects. The mRNA of Icer/ICER was quantiﬁed by quantitative
real-time PCR in WAT of control mice fed with a standard diet (C, white bars) and HFD (H, ﬁlled bars) (A) and in VAT of human nonobese (NO, white
bars) and obese individuals (O, ﬁlled bars) (B). The expression of Atf3/ATF3, Adipoq/ADIPOQ and Glut4/GLUT4 was also monitored in adipose
tissues of obese mice and humans. In all cases, the results were normalized against the housekeeping acidic ribosomal phosphoprotein P0 gene (Rplp0/
RPLP0) and those of the control mice (C) or nonobese human (NO) cells were set to 100%. Data are the mean6 SEM for 10 mice or 5 humans for each
group that was repeated three times (***P < 0.001; **P < 0.01; *P < 0.05). C: Measurement of Icer, Atf3, Adipoq, and Glut4 protein contents by
Western blotting experiments. Total (for Icer, Adipoq, and Glut4) and nuclear (for Atf3) proteins were prepared from WAT of obese (H) or control
(C) mice. Proteins (50 mg) were loaded into a SDS-polyacrylamide gel. Identiﬁcation of the CRE-binding activities in WAT of obese and control mice
(D) and VAT of obese and nonobese individuals (G and I). Nuclear extracts were incubated with the radioactive probe containing the consensus Cre
(CRE). The arrows indicate the major migrating bands. C, CREB; I, ICER; P, Probe. Identiﬁcation of the CRE-binding activity in the WAT of control
(C) (E) and obese mice (H) (F) and nonobese (NO) (H) and obese (O) (J) individuals. For E, F, H, and J, the nuclear extracts were omitted in the
ﬁrst lane (—). Where indicated, the incubation was performed in the presence of 100-molar excess of unlabeled oligonucleotides corresponding to the
CRE sequence or of the binding sequences for the Sp1 transcription factor (Sp-1). Before the addition of the labeled oligonucleotide, nuclear extracts
were preincubated with the antibodies recognizing CREM (CREM) or CREB1 and the unrelated factors hairy and enhancer of Split-1 (HES-1), RE-1
silencing transcription factor (REST), and histone deacetylase 1 (HDAC1) as negative controls (Nsp1, Nsp2, and Nsp3, respectively). Nsp, nonspeciﬁc;
*Supershifted band. For comparison, nuclear extracts of HEK 293T cells transfected with an empty vector (CMV) or with a plasmid producing ICER-Ig
(ICER) were incubated in parallel with the probe. The positions of ICER and of the unbound CRE probe are indicated. The results are representative
of three independent experiments. (A high-quality color representation of this ﬁgure is available in the online issue.)
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correlates with an increase in Creb/CREB activity and ex-
pression of Atf3/ATF3 in adipose tissues from HFD-induced
obese mice and human obese individuals. The adipose re-
duction of Icer/ICER was speciﬁc to adipocytes, indicating
that the rise in Atf3 in this fraction is caused by the loss of
the repressor. In vitro manipulation of the level of the
repressor in 3T3-L1 adipocytes validated Atf3 as a target
gene of Icer and the subsequent modiﬁcation in the ex-
pression of Adipoq and Glut4. Finally, silencing the ex-
pression of Icer hampered DOG uptake, thus conﬁrming the
requirement of appropriate Icer levels for adipocyte func-
tion. In contrast to adipocytes, the expression of Icer
FIG. 2. Expression of Icer/ICER in adipocytes. The mRNA of Icer/ICER was quantiﬁed by PCR in adipocytes and SVF that were collected from WAT
from control (C) and obese mice (H) (A) and VAT from nonobese (NO) and obese individuals (O) (B).C andD: The expression of Atf3/ATF3, Adipoq/
ADIPOQ, and Glut4/GLUT4 was measured in adipocytes of control (C) and obese mice (H) and nonobese (NO) and obese (O) subjects. The mRNA
levels were normalized against Rplp0/RPLP0, and the expression level from controls was set to 100%. Data are the mean6 SEM of three independent
experiments (***P < 0.001; **P < 0.01; *P < 0.05).
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increased in SVF of human obese individuals when com-
pared with control individuals. This observation suggests
that the regulation of ICER differs among cell types, pos-
sibly leading to different modulation of CREB activity in
other cells located within the adipose tissues. Additional
studies will be needed to determine which stromal cell
displays increased ICER levels and to investigate the po-
tential functional impact of this elevation.
Creb activity, and consequently the expression of Icer,
can be induced by various stimuli, including insulin (24,25).
With this respect, we found that insulin elicited a rise in
the expression of Icer in control animals whereas insulin-
induced expression of the repressor was abrogated in insulin-
resistant WAT of obese mice. The fact that the expression
of Icer in WAT of obese animals is reduced both in fed and
fasting conditions, supports an impaired induction of Icer
and, therefore, an abnormal negative control of Creb activity
under stimulatory conditions. This dysregulation could re-
sult in persistently increased CREB activity, in turn leading
to constitutively elevated Atf3 expression and decreased
Glut4 and Adipoq levels. Further studies are now needed
to identify the mechanism leading to impaired expression
of Icer in adipocytes in obesity. We believe that such
investigations may pave the way for the design of novel
therapeutic strategies or for improvement of existing ap-
proaches for recovering normal adipose function and in-
sulin sensitivity.
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FIG. 3. Expression of Atf3 and glucose uptake by manipulating the level
of Icer in adipocytes. 3T3-L1 adipocytes were electroporated with ei-
ther a control plasmid (pcDNA3, white bars) or a plasmid coding for
Icer-Ig (ICER, ﬁlled bars) (A), or with 5 nmol of control RNA duplexes
(siGFP, white bars) or si-ICER (ﬁlled bars) (B). The expression of Atf3
and its target genes Adipoq and Glut4 was monitored by quantitative
PCR 48 h (for Atf3) and 96 h (for Adipoq and Glut4) after transfection.
The levels were normalized against Rplp0, and the expression levels
from cells cultured with vehicle were set to 100%. Data are the mean 6
SEM of three independent experiments (***P < 0.001; **P < 0.01).
Effect of siICER on the abundance of Atf3 and its target genes (C) and
3-O-methyl glucose (OMG) uptake (D). For expression, either nuclear
(for detection of Atf3) or total proteins were prepared from 3T3-L1
cells that were electroporated with 5 nmol/L siGFP (Ctl) or siICER.
Proteins were subjected to Western blotting experiments for the quan-
tiﬁcation of Icer, Atf3, Adipoq, and Glut4 levels using b-tubulin (Tubulin)
as a loading control. The ﬁgure shows the results of a representative
experiment out of three. Measurement of the labeled DOG in 3T3-L1
adipocytes cells was performed 96 h after electroporation with siRNAs.
Data are the mean 6 SEM of three independent experiments (**P <
0.01).
FIG. 4. Schematic representation for the impact of an impaired level of
ICER on the expression of Atf3 and adipocyte function in obesity.
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